| Having trouble viewing this email? View it as a Web page. 
|  "PNU is a prevention and treatment news summary service. NPIN redistributes summaries as a public service. Inclusion of an article does not constitute CDC endorsement of the content. More details in footer."
|  5/5/2014 | National News  | HPV Vaccine Lowering Infection Rates Among Girls: CDC UNITED STATES :: STDs
KnowMore TV (05.04.2014) :: By HealthDay | | | KnowMore TV reported that the human papillomavirus (HPV) vaccine, given to young women between the ages of 14 and 19, has caused a 56-percent decline in the number of new HPV cases in the same age group, according to a new CDC study. HPV is the principal cause of cervical cancer but also can cause other genital organ and oral/throat cancers.
“Herd immunity,” which means widespread vaccination that greatly decreases the number of infected people so it is less likely someone else could get it, may be the reason why the decline is so high.
CDC Director Dr. Tom Frieden said the study results, which were higher than expected, are “striking” and demonstrate the need to “increase [HPV] vaccination rates, because we can protect the next generation of adolescents and young girls against cancer.” The United States’ vaccination rate is only one-third of young females, while some countries are reaching close to 80 percent vaccination coverage. Friedan argued that for every year the United States does not increase the vaccine coverage rate, 4,400 girls who would have otherwise been protected with the vaccine will get cervical cancer later in life.
HPV is a highly contagious STD. Approximately 79 million Americans are thought to have HPV, which causes 19,000 cancers in women and 8,000 cancers in men each year. The vaccine has had some resistance in the United States, with parents reluctant to give their young daughters and sons an STD shot. Frieden says doctors also are responsible for low vaccination rates. “Providers are not consistently giving strong recommendations for the vaccine, and they are not encouraging vaccination at every encounter,” he said. The vaccine continues to prove its safety, with more than 56 million doses provided in the United States with no serious long-term problems reported. |  Read Full Article | Share this Article     | | Back to Top  |  | | Medical News  | Drinking, Even Casual Amounts, Poses Much Greater Risk for Advanced Liver Disease in HIV/Hepatitis C Patients UNITED STATES :: HIV/AIDS,Viral Hepatitis
Science Daily (05.02.2014) | | | Science Daily reported on a study of the effect of alcohol on liver disease in people with HIV and chronic hepatitis C virus (HCV) coinfection. Joseph K. Lim, MD, of Yale University School of Medicine and the Veterans Affairs (VA) Connecticut Healthcare System; senior author Vincent Lo Re III, MD, MSCE, assistant professor of medicine and epidemiology in the Division of Infectious Diseases and Department of Biostatistics and Epidemiology at the University of Pennsylvania and an infectious disease physician at the VA Medical Center in Philadelphia; and colleagues conducted a cross-sectional study of participants from the Veterans Aging Cohort Study.
Of 7,270 participants, 701 were HIV/HCV-coinfected, 1,410 were HIV-positive, 296 were HCV-infected and 1,158 were uninfected with either virus. Participants completed the Alcohol Use Disorders Identification Test–Consumption questionnaire and, based on the results, researchers classified their drinking as alcohol abuse/dependence, nonhazardous drinking, hazardous/binge drinking, and alcohol-related diagnosis.
The researchers found that despite participants’ HIV or HCV status, liver fibrosis increased in relation to alcohol use. Coinfected patients, regardless of level of alcohol use, had the strongest associations compared with uninfected nonhazardous drinkers. The association between alcohol use and fibrosis increased in people with HIV/HCV coinfection, and even light nonhazardous drinking was linked to higher risk of liver fibrosis in coinfected individuals.
The full report, “Relationship Between Alcohol Use Categories and Noninvasive Markers of Advanced Hepatic Fibrosis in HIV-Infected, Chronic Hepatitis C Virus-Infected, and Uninfected Patients,” was published in the journal Clinical Infectious Diseases (2014; 58 (10):1449). | | Read Full Article | Share this Article | | Back to Top | | | | Local and Community News | | News Briefs | | | | |
Học Để Thi Netflix scoops up Tina Fey's 'Unbreakable Kimmy Schmidt' British company reunites...
0 comments:
Post a Comment